Navigation Links
Meningitis vaccine study gets £200,000 boost
Date:2/7/2008

It can kill in four hours and more than 300 people in the UK die from it every year and hundreds more are left with permanent disabilities. Now researchers will work on a potential vaccine for meningitis B, thanks to a 200,000 grant from the medical charity Meningitis UK.

Although vaccines exist to protect against some strains of meningitis, there is still no vaccine to protect against all strains, including the most common in the UK Group B meningococci. This is responsible for almost 90 per cent of all cases and is most common in children under the age of five.

The team, led by Dr Karl Wooldridge, a lecturer in the Centre for Biomolecular Sciences, aim to develop a vaccine against this strain of the bacterium. Group B meningococci mimic molecules in the human body, which makes developing an effective vaccine against this strain very difficult.

Researchers worldwide are searching for alternative antigens molecules that can stimulate an immune response on the surface of the bacteria, which could be used as a basis for a vaccine against meningitis B.

The team has identified a series of autotransporter proteins proteins which are secreted from the surface of Group B meningococci which could be used to create antibodies that will then kill the bacteria.

The grant will be used to fund a two-year research post, examining each of the proteins produced by the bacteria for the potential to create effective antibodies. The genetic code for each protein will be cloned and tagged, allowing the protein to be produced in large amounts and purified for further study.

If we identify one or more of these proteins that give a good protective response we would ultimately move to human trials, said Dr Wooldridge. This would hopefully demonstrate a positive immune response to the vaccine. By identifying a range of active proteins, rather than just one, we could develop a vaccine that targeted all strains of the Group B
'/>"/>

Contact: Karl Wooldridge
karl.wooldridge@nottingham.ac.uk
University of Nottingham
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Schedules Revised for Flu, Meningitis Vaccines
2. New Meningitis Vaccine Works in Infants
3. Steroid Fails to Ease Meningitis in Trials
4. Meningitis Shot Available, Effective Year-Round
5. Tattooing Best Way to Deliver DNA Vaccines
6. Novel molecules developed at UB can boost vaccine potency
7. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
8. Another Study Finds No Link Between MMR Vaccine and Autism
9. New hospital standards needed for pediatric flu vaccines
10. Experimental Vaccine Halts Prostate Cancer in Mice
11. Novel vaccine concept developed by scientists at the Wistar Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...ple adjustments also save money, since side effect... , MONDAY, Oct. 6 (HealthDay News) -- Simple ch...uce the side effects children suffer while on opia...e study, a yearlong collaboration between 14 U.S. ...ease in "harmful events" caused by the pain reliev...
(Date:10/6/2008)... LearnCDHC, a Web-based reso...consumer-directed healthcare (CDHC) options includ...sement Accounts (HRAs) and Flexible Spending Accou...ept Media, to offer enterprise level services in c...l to midsize business model. , ...
(Date:10/6/2008)...ob Brown, Starring as Football Hero and Leukemia V...ia & Lymphoma Society,s 2008 Light The Night(R) ..., N.Y., Oct. 6 /PRNewswire/ -- Ernie Davis, a 1960... to win the Heisman Trophy,is the subject of the ...ing,to theaters Friday, Oct. 10. Davis overcame se...
(Date:10/6/2008)... MONTEREY, Calif., Oct. 6 /PRNewswire/ -- Today, P...tem using eFlow Technology that uses single,dose a...r system. By,creating a proprietary, unit-dose amp...e Closed System using eFlow Technology meets an un...edication in the delivery device,simplifying fill...
Breaking Medicine News(10 mins):Health News:Hospital Fixes Cut Opiate Errors in Kids 2Health News: LearnCDHC Bridges Education Gap on Consumer Directed Healthcare : Interactive Web resource engages and educates consumers about consumer-directed healthcare 2Health News: LearnCDHC Bridges Education Gap on Consumer Directed Healthcare : Interactive Web resource engages and educates consumers about consumer-directed healthcare 3Health News:Release of Universal Film The Express Draws Attention to Tragedy of Lives Cut Short by Blood Cancer 2Health News:PARI Pharma Unveils Closed System Using eFlow Technology at Medical Plastics Conference 2
... response to the global burden imposed by the wide...nical drug trials involving herbal medicines. //It... are afflicted with the disease. The initiative w...edies in the treatment of AIDS/HIV. About 14 natur...
...growing number of animal and human studies show th... unexpected changes in pain sensitivity, resulting...nse to painful// stimulation) and allodynia (abnor...inful stimulation). Interestingly, prev...
...ofessor Vittorio Demicheli an Italian epidemiologi...involving the use of Mumps, Measles and Rubella (M...e link between MMR vaccination and autism or bowel...ne shots in children’s may cause Autism. This revi...
...searchers say low levels of low density lipoprotei...afe for heart patients who are taking statins.// T...LDL cholesterol from over 200 milligrams/deciliter...o one knows whether such levels are safe. Dr. Chri...
Other Medicine News:Health News:Opioids And Abnormal Pain Perception 2Health News:MMR Vaccination not linked to Autism 2
(Date:10/6/2008)...ent of moderate to severe patients achieved endosc...doscopic remission at Week 10,in data from a 54-we...ege,of Gastroenterology (ACG) Annual Scientific Me...today presented data from a,large, prospective stu...,disease (CD) with a biologic compound. The data p...
(Date:10/6/2008)...- Dendreon Corporation (Nas...ay, October 6, 2008 at 9:00 AM,ET (6:00 AM PT) to ...IMPACT,(IMmunotherapy for Prostate AdenoCarcinoma ... PROVENGE(R) (sipuleucel-T), the Company,s investi...atment of advanced prostate,cancer., Those int...
(Date:10/3/2008)..., New Jersey is the newest study site, PHILADELPH...,s Hospital,of Philadelphia today received a contr...ldren,s Study. Children,s Hospital will manage loc...in Burlington County, New,Jersey. The study is fun...igators anticipate approximately 1,000 families in...
(Date:10/2/2008)...rgent PC clinical success and expanded reimburseme...APOLIS, Oct. 2 /- Uroplasty...of the first patients in a new,randomized, control...Urgent,PC neuromodulation system for the treatment...rgency, urge incontinence and frequency of urinary...
Breaking Medicine Technology:CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 2Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 3Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 4Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 1Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 2Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 3Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 4Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 5Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 6Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 7Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 8Baxter to Launch GARDian 28TM 29 a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 156 9Biopure Gives Update on Malaysia Joint Venture Discussions 151 1Biopure Gives Update on Malaysia Joint Venture Discussions 151 2Biopure Gives Update on Malaysia Joint Venture Discussions 151 3Many Older Americans Have Active Sex Lives 151 1Many Older Americans Have Active Sex Lives 151 2Many Older Americans Have Active Sex Lives 151 3Many Older Americans Have Active Sex Lives 151 4FDA Approves First Anti Psychotic for Kids 148 1FDA Approves First Anti Psychotic for Kids 148 2FDA Approves First Anti Psychotic for Kids 148 3
...SHINGTON, June 20, 2007 /PRNewswire-USNewswire/ --...n issued the following,statement today after Presi... by vetoing the Stem Cell Research Enhancement Act...ding for life-saving,embryonic stem cell research,...le and passed both the House and Senate with,bipar...
...FORD, England, 20 June 2007 - VASTox plc (AIM: VOX...hat it has been awarded a,grant of £400,000 ...) under the SMARTCymru scheme. The grant,which r...evelopment,work undertaken at VASTox’s Abery...ique skills and expertise of its scientists,based ...
Other Medicine Technology:Dean: President Bush Has Turned His Back on the American People 2Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 2Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 3
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: